1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation
Drug Research · 01.04.2025 · 75 (03/04) · 94-99
DOI: 10.1055/a-2463-5530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.04.2025. Verfasst von Yihan Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Eighth Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Transforming Growth Factor beta1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
To investigate the effect of 1α,25(OH)2D3 on hepatic stellate cells and the mechanism of the TGF-β1/Smad signaling pathway. LX2 cells were treated with TGF-β1 and different concentrations of 1α,25(OH)2D3. Cell proliferation was assessed using the CCK8 assay to determine the optimal concentration of 1α,25(OH)2D3 activity. The cell cycle and apoptotic rates were evaluated using flow cytometry. The expressions of Samd2, Samd3, Samd4, and Samd7 was assessed by western blotting, whereas the expression of MMP1, MMP13, and TIMP-1 was detected by qPCR. Compared with the control group, the 1α,25(OH)2D3 group had a higher apoptotic rate of LX2 cells, the cell cycle was blocked from the G1 stage to the S stage, the expressions of Samd2, Samd7, MMP1, and MMP13 increased, while the expressions of Samd3, Samd4, and TIMP-1 decreased. 1α,25(OH)2D3 inhibits hepatic stellate cell activation and exerts anti-hepatic fibrosis effects by downregulating the expression of Samd3, Samd4, TIMP-1 and upregulating the expression of Samd2, Samd4, MMP1, and MMP13.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Xi'an Eighth Hospital, Xi'an, China.
- Second Clinical College, Shaanxi University of Traditional Chinese Medicine, Xianyang, China.
Zitieren
APA
Zhao, Y., Fan, J., Wang, J., Wan, J., Ma, H., Sha, X., & Wang, H. (2025). 1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation. Drug Research, 75(03/04), 94-99. https://doi.org/10.1055/a-2463-5530
Vancouver
Zhao Y, Fan J, Wang J, Wan J, Ma H, Sha X, et al. 1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation. Drug Research. 2025;75(03/04):94-99. doi:10.1055/a-2463-5530
BibTeX
@article{Zhao2025,
author = {Zhao, Yihan and Fan, Jianghao and Wang, Jia and Wan, Jie and Ma, Haiyan and Sha, Xiaoying and Wang, Hongli},
title = {1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation},
journal = {Drug Research},
year = {2025},
volume = {75},
number = {03/04},
pages = {94--99},
doi = {10.1055/a-2463-5530}
}
EUVIMED